Literature DB >> 15855719

Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition.

Yoshimichi Sai1.   

Abstract

Membrane transporters are integral membrane proteins typically having 12 transmembrane domains. Most of the SLC family transporters consist of 300-800 amino acid residues with a molecular mass of 40-90 kDa, while the corresponding values of ABC family transporters are 1,200-1,500 residues and 140-180 kDa, respectively. Each transporter has a characteristic tissue distribution and subcellular localization. I have isolated cDNAs of various transporters, including oligopeptide transporter PEPT1, monocarboxylic acid transporter MCT1 and organic cation/carnitine transporters (OCTNs), and determined their tissue distribution and subcellular localization. I have also determined the absolute expression levels of transporters to evaluate their relative contributions to drug transport in various tissues. It is important to note that expression levels of transporters can be changed under various physiological conditions and by administration of drugs. Changes in expression level, subcellular localization and functional properties can all be involved in inter-individual differences in drug pharmacokinetics. Transporters are among the key determinants of drug disposition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855719     DOI: 10.2133/dmpk.20.91

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  17 in total

1.  Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.

Authors:  Kunio Fujiwara; Masashi Shin; Yohei Yoshizaki; Tsubasa Miyazaki; Tetsuya Saita
Journal:  J Mol Histol       Date:  2011-10-18       Impact factor: 2.611

Review 2.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

3.  Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.

Authors:  Huangyu Jiang; Jia Yu; Haihui Zheng; Jiamei Chen; Jinjun Wu; Xiaoxiao Qi; Ying Wang; Xinchun Wang; Ming Hu; Lijun Zhu; Zhongqiu Liu
Journal:  Pharm Res       Date:  2017-04-18       Impact factor: 4.200

4.  Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes.

Authors:  Eskouhie H Tchaparian; Jessica S Houghton; Craig Uyeda; Mark P Grillo; Lixia Jin
Journal:  Drug Metab Dispos       Date:  2011-08-24       Impact factor: 3.922

5.  Adaptive response to increased bile acids: induction of MDR1 gene expression and P-glycoprotein activity in renal epithelial cells.

Authors:  Carsten Kneuer; Walther Honscha; Gotthold Gäbel; Kerstin U Honscha
Journal:  Pflugers Arch       Date:  2007-02-27       Impact factor: 3.657

Review 6.  Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.

Authors:  John J Lima
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

7.  Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.

Authors:  Diana Vivian; James E Polli
Journal:  Eur J Pharm Sci       Date:  2014-08-27       Impact factor: 4.384

8.  Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol.

Authors:  M l Broberg; R Holm; H Tønsberg; S Frølund; K B Ewon; A l Nielsen; B Brodin; A Jensen; M A Kall; K V Christensen; C U Nielsen
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 9.  Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.

Authors:  Jeremiah D Momper; Sanjay K Nigam
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-06-04       Impact factor: 4.481

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.